Abstract
Estradiol (E2) modulates affective and socio-sexual behavior of female rodents. E2's functional effects may involve actions through α and β isoforms of estrogen receptor (ERs). The importance of E2's actions at these isoforms for anxiety (open field, elevated plus maze), depression (forced swim test), and sexual behavior (lordosis) was investigated using an antisense oligonucleotide (AS-ODN) strategy. If ERβ is required for anti-anxiety and antidepressant-like effects, and ERα is required for sexual receptivity, of E2, then intracerebroventricular administration of AS-ODNs against these ERs should attenuate these effects and reduce immunoreactivity of ERs in brain regions that mediate these behaviors, such as the hippocampus and ventral medial hypothalamus (VMH). Ovariectomized rats were primed with 17β-E2 (10 μg) 48 h before testing (hour 0). At hours 0, 24, and 47.5, rats were infused with saline vehicle, scrambled control AS-ODNs, or AS-ODNs targeted against ERα and/or ERβ, and were tested at hour 48. Rats infused with ERβ AS-ODNs, alone, or with ERα AS-ODNs had significantly decreased open field central entries, decreased plus maze open arm time and entries, increased time spent immobile, and decreased time spent swimming in the forced swim test, and decreased ERβ immunoreactivity in the brain than did rats administered ERα AS-ODNs, vehicle, or scrambled AS-ODNs. Rats that were administered ERα AS-ODNs, alone, or with ERβ AS-ODNs had significantly decreased lordosis and decreased ERα immunoreactivity in the brain compared to rats administered ERβ AS-ODNs, vehicle, or scrambled AS-ODNs. Thus, ERβ and ERα may be required for E2's modulation of affective and sexual behavior, respectively.
Similar content being viewed by others
INTRODUCTION
Estrogen's effects in the central nervous system include modulation of affective and sexual behavior. Naturally, sexually receptive rats in proestrus have higher estradiol (E2) levels and reduced anxiety/depression behaviors compared to diestrous rats (Frye and Bayon, 1999; Frye et al, 2000; Frye and Walf, 2002). These effects are mimicked in ovariectomized (ovx) rats administered E2 regimen that produces proestrous-like levels of E2 (Pfaff, 2005; Walf and Frye, 2006a). Intracellular E2 receptors (ERs), the originally identified E2 binding site (ie ERα) and another ER isoform (ie ERβ; Kuiper et al, 1996), are one of E2's potential substrates for their functional effects. Although DNA and ligand-binding domains are similar, these ER isoforms have distinct encoding genes, effects on gene regulation and patterns of expression (Kuiper et al, 1998). As described below, differential distribution of ER isoforms in the brain suggests that E2 may have ERα- and/or ERβ-specific functional effects.
The hippocampus may be important for E2's effects on anxiety and depression behaviors. Administration of ER antagonists, which are not specific for ER isoforms, subcutaneously (tamoxifen) or to the hippocampus (ICI 182780) similarly attenuate E2's anti-anxiety and antidepressant-like effects (Walf and Frye, 2005b, 2006a). The hippocampus primarily expresses ERβ (Shughrue et al, 1997; Shughrue and Merchenthaler, 2001). Studies in ERβ knockout mice suggest that ERβ is required for affective behavior as these mice have increased anxiety and depression behavior, which is not reversed by E2 administration (Krezel et al, 2001; Imwalle et al, 2005; Rocha et al, 2005; Walf and Frye, 2006a). Administration of selective ER modulators (SERMs) that have greater affinity for ERβ than ERα to ovx rats decrease anxiety and depressive behavior when administered subcutaneously or to the hippocampus (Walf et al, 2004; Walf and Frye, 2005b, 2007). Thus, ERβ in the hippocampus is a likely target for E2's actions and effect.
Sexual behavior of female rats may involve actions of ERα in the ventral medial hypothalamus (VMH). The mating posture of female rodents, lordosis, depends upon initiation by E2 in the VMH (Pfaff, 1980, 1999, 2005). Administration of E2 to the VMH promotes lordosis and E2's effects can be obviated by subcutaneous administration of ER antagonists or blockade of ER binding in the VMH (Etgen and Shamamian, 1986; Etgen, 1987; Pleim et al, 1989). ER expression in the VMH is primarily ERα (Shughrue et al, 1997, 1998). Studies in ER knockout mice and using ERα-specific SERMs suggest that ERα is critical for lordosis (Ogawa et al, 1998, 2003; Walf and Frye, 2005b). Thus, ERα in the VMH may be required for the effects of E2 for lordosis.
Studies using ER knockout mice address the effects of lifetime ER knockdown, but not acute effects in specific brain regions. In the present study, E2-primed ovx rats were infused ERα and/or ERβ antisense oligodeoxynucleotides (AS-ODNs) intracerebroventricularly (ICV) and tested in the open-field, elevated plus maze, forced swim test, and for sexual receptivity, and brains were collected for immunohistochemical evaluation of hippocampal ERβ expression and hypothalamic ERα expression to verify efficacy of ICV AS-ODN administration. If ERβ in the hippocampus is required for effect, and ERα in the hypothalamus is required for sexual receptivity, then ERα and/or ERβ AS-ODNs should attenuate E2's effects and reduce immunostaining for ERβ in the hippocampus and ERα in the VMH, respectively.
MATERIALS AND METHODS
These methods were pre-approved by the Institutional Animal Care and Use Committee at SUNY Albany.
Animals and Housing
Adult (55+ days old), female Long-Evans rats (n=50) were obtained from the breeding colony in the Social Sciences and Life Sciences Research Buildings in the Laboratory Animal Care Facility at SUNY-Albany (original stock from Taconic Farms, Germantown, NY). Rats were group-housed (4–5 per cage) in polycarbonate cages (45 × 24 × 21 cm) in a temperature-controlled room (21±1°C). Rats were maintained on a 12/12 h reversed light cycle (lights off at 0800 h) with continuous access to Purina Rat Chow and tap water.
Surgery
Young adult (55 days old) rats were ovx under Rompun (12 mg/kg; Bayer Corp., Shawnee Mission, KS) and Ketaset (80 mg/kg; Fort Dodge Animal Health, Fort Dodge, IA) anesthesia. One week later, rats had stereotaxic surgery and were implanted with 23-gauge cannula to the right lateral ventricle (ICV; from bregma AP=1.0, ML=1.6, DV=5.5; as per Paxinos and Watson (1986); Frye and Duncan (1996) under the same anesthesia regimen. Placement of cannula was determined the following day (see below for details) and then rats were E2-primed, administered AS-ODNs, and behaviorally tested 1 week later.
Determination of Cannula Placement
To determine cannula placement, rats were infused with Angiotensin II (Sigma; 100 ng/μl), which reliably induces drinking behavior when administered to the lateral ventricle (Phillips, 1978). Rats were then tested for their latency to drink and number of licks made during a 3 min test (Anxiometer; Columbus Instruments, Columbus, OH). Rats that did not drink water when infused with Angiotensin II (n=3) were administered saline vehicle in the experiment and their data did not differ from rats that drank water when administered Angiotensin II and were administered saline vehicle in the experiment.
E2-Priming
All rats were administered 10 μg 17β-E2 (Steraloids, Newport, RI) dissolved in vegetable oil vehicle 48 h before testing (Walf and Frye, 2005a). This E2 dosing regimen was chosen as it has previously been shown to increase anti-anxiety, antidepressant-like, and sexual behavior of ovx rats (Walf et al, 2004; Walf and Frye, 2005a). Note that although progesterone administration would produce greater sexual responses in E2-primed ovx rats than E2 alone, progestins alter the end points utilized and these studies were designed to investigate specifically the effects of E2.
Experimental Groups
Rats were randomly assigned to one of five experimental groups (n=10/group) that received saline vehicle, scrambled control oligodeoxynucleotides, ERα AS-ODNs, ERβ AS-ODNs, or both ERα and ERβ AS-ODNs.
Infusions
Rats were infused with 1 μl of modified full-length phosphorothioate HPLC-purified mRNA AS-ODNs, scrambled control oligodeoxynucleotides, or saline vehicle three times. Although these AS-ODNs were modified, and should be metabolized less quickly than unmodified ODNs, rats received three infusions throughout E2-priming. The first infusion was done immediately before administration of E2 (ie 48 h before behavioral testing), 24 h later, and 30 min before testing (2000 ng/μl in saline; Liang et al, 2002). AS-ODNs were obtained from Genomechanix (Gainesville, FL). Sequences were 5′-CATGGTCATGGTCAG-3′ for ERα AS-ODNs, 5′-GAATGTCATAGCTGA-3′ for ERβ AS-ODNs, 5′-ATCGTGGATCGTGAC-3′ for ERα scrambled control AS-ODNs (Liang et al, 2002; Walf et al, 2006a; Edinger and Frye, 2007).
Behavioral Testing
Data from rats were collected by hand by an observer and/or with a video-tracking system (Any-Maze, Stoelting, Wood Dale, IL). There was a greater than 95% concordance in data collected with these methods and in the two buildings. Rats were tested on one occasion in a battery of all of the following tasks in the order indicated below. Rats were tested between 1200 and 1600 h.
Open Field
The open field (76 × 57 × 35 cm) has a 48-square grid floor and was situated in a brightly lit room. As per previously published methods, the number of central and peripheral squares, which were summed for total, that each rat entered during the 5 min test were recorded (Frye et al, 2000). Total entries made are an index of general motor behavior, and an increased number of central entries is an index of anti-anxiety behavior.
Elevated Plus Maze
The elevated plus maze was situated in a brightly lit room and consisted of four arms (two open without walls and two enclosed by 30 cm high walls) 49 cm long and 10 cm wide, elevated 50 cm off the ground. Rats were placed at the junction of the open and closed arms and the number of entries and time spent on the open and closed arms were recorded (according to Frye et al, 2000). Total entries made in the plus maze are an index of general motor behavior and an increase in time spent, and entries made, on the open arms indicates anti-anxiety behavior.
Lordosis Testing
Rats were tested for sexual behavior (ie lordosis quotients) in a Plexiglas chamber (50 × 25 × 30 cm) in the brightly lit testing room with a sexually experienced adult male. Females were placed in the chamber and the number of lordosis postures assumed when mounted by the male within 10 total mounts or test minutes, whichever came first. The number of times that the female assumed the lordosis posture as a function of the number of mounts made by the male (lordosis quotients) were used as an index of sexual receptivity (Hardy and DeBold, 1971; Walf and Frye, 2005b).
Forced Swim Test
The forced swim test was utilized as per previously published methods (Frye and Walf, 2002). Rats were tested in the forced swim test in a chamber filled with 30 cm of 30°C water. Time spent by the rat struggling to get out of the chamber, swimming underneath the surface of the water, or completely immobile except for the minimal movements necessary to keep nose above water and the number of fecal boli produced by rats were recorded during the 10-min task. Struggling and swimming can be considered as indices of general motor behavior and a decrease in time spent immobile indicates anti-depressant-like behavior. The number of fecal boli is considered an ethologically relevant index of anxiety/fear in rodents.
Perfusion
Immediately following testing, rats were overdosed on sodium pentobarbital (150 mg/kg; perfused via intra-cardiac puncture with a needle attached to tubing that pumped 100 ml phosphate-buffered saline (PBS) and then 250 ml of fixative (4% paraformaldehyde) through tissue. Brains were stored in fixative and then in a 30% sucrose PBS solution followed by rinsing and storage in 0.2 M PBS.
Immunohistochemistry
The behavioral data obtained suggest that concentrations of AS-ODNs (which can sharply decline away from the ventricle after infusion) utilized were effective. Immunohistochemical analyses of brain regions that are known to be involved in E2's effects on anxiety and reproduction, the hippocampus (Walf and Frye, 2007) and VMH (Pleim et al, 1989), were performed. Brains were cut on coronal sections at 50 μm using a Vibratome. After obtaining all the sections, two separate immunohistochemistry assays for ERα and ERβ, respectively, were performed as per modified methods (Garcia-Ovejero et al, 2002). The primary antisera used to detect the antigen was ERα, MC20, purchased from Santa Cruz Biotechnology (Santa Cruz, CA), diluted 1 μg/ml; ERβ, purchased from Affinity Bioreagents, diluted 1 : 2000. Rinses and incubations were done on free-floating sections under moderate shaking. Sections were first rinsed in 0.1 M phosphate-buffered saline (pH 7.4), containing 0.3% Triton X-100 and 0.3% Bovine albumin serum; subsequent washes used this same rinsing solution. Endogenous peroxidase activity was inhibited by incubating the sections in 0.1 M phosphate buffer containing 0.9% H2O2 and 30% methanol. After shaking in the rinsing solutions three times for 10 min each wash, sections from both immunohistochemistry assays were incubated separately for two nights in the rabbit IgG polyclonal primary antisera against ERα and ERβ in 3% normal goat serum. After careful washes, sections were incubated for 2 h at room temperature with biotinylated goat anti-rabbit antibody (Vector, Burlingame, CA; 1:250). Sections were incubated for 90 min with a complex avidine-biotin peroxidase, diluted 1:300 (ABC, Pierce). Peroxidase reaction product was revealed by incubating the sections in a solution of 0.03% diaminobenzidine and 0.01% hydrogen peroxide in 0.1 M phosphate buffer. Sections were dehydrated and mounted carefully and subsequently examined on a Leica DMRB-E microscope.
Morphometric Analysis
The number of ERα and ERβ immunoreactive neurons in CA1 pyramidal layer of the hippocampus and in the ventromedial nucleus of the hypothalamus was estimated by the optical disector method (Howard and Reed, 1998) using total section thickness for disector height (Hatton and von Bartheld, 1999) and a counting frame of 55 × 55 μm. A total of 10 counting frames were assessed per animal. Section thickness was measured using a digital length gauge device (Heidenhain-Metro MT 12/ND221; Traunreut, Germany) attached to the stage of a Leitz microscope. Cell nuclei from immunoreactive neurons that came into focus while focusing down through the disector height were counted. All counts were performed blind.
Statistical Analyses
One-way analyses of variance (ANOVAs) were used to examine effects of ICV treatment for behavioral end points and number of immunoreactive cells in the brain. To take into account differences in general motor activity in the tasks utilized, measures of affective behavior in the open field (central entries), elevated plus maze (open arm entries), and forced swim test (immobility), were standardized (expressed as % of total activity) and are depicted in Figures 1, 2 and 3. Raw means (±SD; SEM) of these measures and general motor measures are included in the results section and Table 1, respectively. Given that multiple comparisons were made, Tukey's post hoc tests were utilized to determine group differences, as appropriate. Differences were considered significant when P<0.05.
RESULTS
Open Field
There was a main effect of infusion condition for central entries made, as a function of total entries made, in the open field (F(4,45)=23.73, P<0.01) (see Figure 1). Post hoc tests revealed that infusions of ERβ (5.9±4.5 SD; 1.4 SEM) or ERα/ERβ (4.8±6.0 SD; 1.9 SEM) AS-ODNs significantly decreased central entries compared to infusions of ERα AS-ODNs (33.9±15.4 SD; 4.9 SEM), saline vehicle (28.5±12.9 SD; 4.1 SEM), or scrambled control AS-ODNs (27.6±12.8 SD; 4.0 SEM).
There was a main effect of infusion condition to alter total entries made in the open field, such that rats administered ERα AS-ODNs made more total entries than did rats administered ERα/ERβ AS-ODNs infusions (F(4,45)=3.63, P<0.01) (Table 1).
Elevated Plus Maze
There was a main effect of AS-ODN infusions to alter the number of open arm entries, expressed as a percentage of total arm entries in the plus maze (F(4,45)=6.04, P<0.01) (Figure 2). Post hoc test revealed that infusions of ERβ (1.7±1.6 SD; 0.5 SEM) or ERα/ERβ (1.1±1.2 SD; 0.4 SEM) AS-ODNs significantly decreased the entries made on the open arms of the elevated plus maze compared to infusions of ERα AS-ODNs (3.5±2.0 SD; 0.6 SEM), saline vehicle (2.8±1.2 SD; 0.4 SEM), or scrambled control AS-ODNs (2.8±1.3 SD; 0.4 SEM). A similar pattern was observed for open arm time (F(4,45)=9.03, P<0.01), such that infusions of ERβ (15.7±17.5 SD; 5.5 SEM) or ERα/ERβ (4.6±6.5 SD; 2.0 SEM) AS-ODNs significantly decreased open arms time compared to that seen in rats infused with ERα AS-ODNs (46.7±28.3 SD; 8.9 SEM), saline vehicle (52.3±27.6 SD; 8.7 SEM), or scrambled control AS-ODNs (45.8±25.0 SD; 7.9 SEM).
ICV infusions of ERα AS-ODNs significantly increased total, but not closed, arm entries made in the elevated plus maze compared to infusions of ERα/ERβ AS-ODN (F(4,45)=2.73, P<0.04) (Table 1).
Forced Swim Test
There was a main effect of infusion condition for duration of immobility (as a function of time spent swimming) in the forced swim test (F(4,45)=9.21. P<0.01) (Figure 3). Infusions of ERβ (328.2±33.3 SD; 10.5 SEM) and ERα/ERβ (325.9±48.96 SD; 15.48 SEM) AS-ODNs significantly increased the duration spent immobile compared to that observed in rats administered infusions of saline vehicle (190.5±21.99 SD; 6.9 SEM), scrambled control AS-ODNs (180.3±38.7 SD; 12.2 SEM), or ERα AS-ODNs (181.4±22.9 SD; 7.3 SEM).
ICV infusions of ERα/ERβ AS-ODN significantly decreased duration spent swimming compared to infusions of saline vehicle, scrambled AS-ODNS, or ERα AS-ODNs (F(4,45)=11.7, P<0.01) (Table 1). There were no significant differences between groups for duration spent struggling in the forced swim test (Table 1).
Although rats administered ERβ AS-ODNS ICV had the greatest mean number of fecal boli produced in the forced swim test, statistical analyses of group differences for this measure did not reach statistical significance (P=0.06; data not shown).
ERβ Immunoreactivity
Effectiveness of AS-ODNs utilized was verified by reduced ERβ immunoreactivity in VMH (F(3,8)=323.7, P<0.01) and hippocampal (F(3,8)=36.8, P<0.01) (Figure 4) sections of rats administered ICV ERβ or ERα/ERβ AS-ODNs compared to that in rats administered ICV saline or scrambled AS-ODNs (Table 2).
Sexual Receptivity Test
There was a main effect of infusion condition for lordosis quotients, such that infusions of ERα and ERα/ERβ AS-ODNs significantly decreased lordosis quotients compared to infusions of saline vehicle, scrambled control AS-ODNs, or ERβ AS-ODNs (F(4,45)=9.31, P<0.01) (Figure 5).
ERα Immunoreactivity
Effectiveness of AS-ODNs utilized was verified by lowered ERα immunoreactivity in the VMH (F(3,8)=238.5, P<0.01) (Figure 6) and hippocampus (F(3,8)=46.2, P<0.01) of rats administered ICV ERα or ERα/ERβ AS-ODNs compared to those administered ICV saline or scrambled AS-ODNs (Table 2).
DISCUSSION
These results supported our hypothesis that E2's effects for anxiety/depressive and sexual behavior may be through actions involving ERβ and ERα, respectively. In support, rats administered ERβ or ERα/ERβ AS-ODNs ICV had decreased central entries in the open field, decreased open arm time/entries in the plus maze, increased time spent immobile in the forced swim test, and decreased immunoreactivity for ERβ in the brain (VMH and CA1) compared to rats administered saline vehicle or scrambled control AS-ODNs, or ERα AS-ODNs. These effects were not solely due to gross changes in motor behavior of rats in these tasks. Rats administered ERα or ERα/ERβ AS-ODNs ICV had decreased lordosis quotients and immunoreactivity for ERα in the VMH and hippocampus compared to rats administered saline vehicle or scrambled control AS-ODNs, or ERβ AS-ODNs. Together, these results suggest the importance of ERβ for affective behavior and ERα for sexual receptivity.
The present study using a short-term regimen of AS-ODNs targeted towards ERs contributes to the existing literature on the role of ERα and/or ERβ knockdown for behavior. Studies utilizing transgenic mice that do not express ERα and/or ERβ demonstrate that knockout of these receptors throughout the lifespan have specific behavioral effects. ERβ, but not ERα, knockout mice have increased anxiety and depressive behavior compared to their wild type counterparts (Krezel et al, 2001; Imwalle et al, 2005; Rocha et al, 2005; Walf and Frye, 2006a), but their reproductive behavior is intact (Ogawa et al, 1999). On the other hand, ERα knockout mice are infertile and are not sexually receptive when in contact with a sexually experienced male (Ogawa et al, 1998; Ogawa et al, 2003). Indeed, a similar pattern of behavioral responses was observed in ovx, E2-primed rats in the present study that were administered ERα AS-ODNs. Administration of ERβ AS-ODNs three times throughout the 48 h of E2-priming before behavioral testing attenuated the anti-anxiety and antidepressive effects of E2, but did not alter lordosis. Whereas, ERα AS-ODNs administered for the same time period attenuated lordosis quotients without altering anxiety and depressive responses. Thus, these data suggest that there are specific functional effects of E2 at ERα and ERβ, but the possibility ERα and ERβ that share some cross-regulatory actions for E2's behavioral effects remains to be addressed.
The results of this study confirm previous studies from our laboratory and others on the role of ERα and ERβ for specific behavioral processes in adult rodents and extend these findings to suggest some brain targets for these effects, the hippocampus, and VMH; albeit, in the present study, ER expression in these brain areas was investigated as a means to determine effectiveness of AS-ODNs strategy employed to knockdown expression of ERα and ERβ in the brain. In the present study, ovx, E2-primed rats administered ERβ AS-ODNs had decreased anti-anxiety and anti-depressive behavior and reduced ERβ-immunoreactivity in the brain, compared to rats administered control infusions or ERα AS-ODNs demonstrating that ERβ-ODNs were effective in knocking down ERβ. Previous work has shown that systemic administration of 17β-E2, which would be expected to affect the whole brain, produces similar effects to increase anti-anxiety and anti-depressant-like behavior of ovx rodents as does direct hippocampal administration of E2 (Slater and Blizard, 1976; Rachman et al, 1998; Frye and Wawrzycki, 2003; Frye and Walf, 2004; Walf et al, 2004; Walf and Frye, 2005a, 2005b, 2006a, 2007). Effectiveness of ERα AS-ODN administration to knock down ERα is revealed by reduced ERα immunoreactive cells in the brain in ovx, E2-primed rats administered ERα AS-ODNs compared to rats administered control infusions or ERβAS-ODNs demonstrating that ERα-ODNs were effective in knocking down ERα. Indeed, E2 administration to the VMH increases lordosis of ovx female rodents (Pleim et al, 1989). Given that 17β-E2 has equal affinity for ERα and ERβ, an interesting question is whether the observed effects for 17β-E2 when administered to the hippocampus or VMH are also observed with ERα or ERβ specific SERMS. We have recently shown that SERMs that are selective for ERβ decrease anxiety and depressive behavior when administered to the hippocampus, but not to a control missed site that expresses ERβ, the ventral tegmental area; these effects are similar to that observed with subcutaneous administration of SERMs and ERα-specific SERMs were ineffective (Lund et al, 2005; Walf et al, 2004; Walf and Frye, 2005b, 2007). Furthermore, subcutaneous administration of ERα-, but not ERβ-, SERMs increase lordosis similar to that observed in ovx rats administered 17β-E2 (Walf and Frye, 2005b). Together, these data suggest that ERβ in the hippocampus and ERα in the VMH may be important sites to investigate more directly for E2's modulation of affective and socio-sexual behavior, respectively.
These data suggest that actions of ERβ and ERα are necessary and sufficient for E2's effects on anxiety/depression and sexual behavior, respectively; however, a few issues regarding this interpretation need to be addressed. First, other factors that may have influenced the results observed were not investigated in the present study. As one example, oxytocin may be involved in the effects observed. E2 induces the oxytocin gene, which is dependent upon ERβ, and oxytocin is involved in both affective and social responses (Nomura et al, 2002; Choleris et al, 2003). Furthermore, examining the effects of ER AS-ODN treatment to vehicle-administered ovx rats would provide additional information about the importance of ER function for these behavioral effects. Indeed, the downstream effectors of ERs, which may be membrane-bound and/or have membrane actions that potentiate intracellular events, such as extracellular regulated kinase/mitogen-activated protein kinase, need to be elucidated (Wade and Dorsa, 2003; Bryant et al, 2005; Vasudevan et al, 2001, 2005; Mhyre and Dorsa, 2006). In the future, it would be important to address these points. Second, although the hippocampus and VMH are logical areas to begin investigating the brain region- and ER subtype-specific effects of E2 for anxiety, and socio-sexual behavior, it is likely that these are not the only brain regions involved in the behavioral effects observed. For instance, direct E2 administration to the medial amygdala or median raphe nucleus decreases anxiety and depressive behavior of ovx rats demonstrating that these brain regions are sensitive to E2's effects and involved in affective responses (Walf and Frye, 2003; Andrade et al, 2005; Walf and Frye, 2006). Indeed, in the case of the amygdala, ERα and ERβ expression varies with reproductive status and mating stimuli (Greco et al, 2003a, 2003b). In the present study, immunohistochemistry was utilized as a means to verify that ICV administration of ER AS ODNs produced qualitative changes in expression of ERα and ERβ in the brain. Although Western blot analyses, which would provide another biochemical indicator of the effectiveness of AS-ODN treatment, could not be performed on subjects from the present study, we have previously demonstrated with Western blotting that administration of these ER AS ODNs directly to the striatum or hippocampus reduce ER levels in these regions concomitant with robust behavioral changes (Walf et al, 2006a; Edinger and Frye, 2007). Future studies could further investigate whether such treatments, when infused ICV or directly to these brain regions of interest, produce qualitative and quantitative changes in receptor expression using both Western blotting and immunohistochemistry. Third, the known effects for activity/arousal of E2s, which are clearly dependent upon the environmental context before and during behavioral assessment (see Morgan et al, 2004 for a review), may have influenced the present results. High circulating E2 levels, as occurred during behavioral estrous or when E2 is administered to ovx rodents, increase spontaneous motor activity (Joyce and Van Hartesveldt, 1984; Becker, 1990; Becker et al, 1987; Morgan and Pfaff, 2001, 2002), and these effects may be ERα-specific (Ogawa et al, 2003). However, a different pattern of effects for motor activity is observed in a novel open field and/or in different lighting (see Morgan et al, 2004 for a review), and these effects in tasks involving novelty/anxiety, such as the open field, may be primarily mediated by E2's actions at ERβ (Krezel et al, 2001). In the present study, when motor behavior in the tasks was compared between groups, a distinct pattern to account for changes in the anxiety or depression measures utilized was not found across all tasks. For instance, infusions of ERα AS-ODNs increased total entries in the open field and elevated plus maze compared to infusions of ERα/ERβ AS-ODNs, but behavior of other groups was similar. In the forced swim test, infusions of ERβ or ERα/ERβ AS-ODNs decreased swimming compared to all other groups, but there was no effect on struggling behavior in the task. Additionally, it is important to note that there was no evidence for non-specific behavioral effects of the AS-ODNs, which may have obviated interpretation of the behavioral effects observed. Indeed, further investigation of ER mechanisms, brain regions of interest, role of context, and effects of arousal/activity for behavioral effects observed is warranted.
These data are interesting as they begin to dissociate mechanisms of E2 at ERα and ERβ as well as brain targets for these effects. The lifetime prevalence rates for anxiety and depression disorders among women are approximately twice than that seen in men (Breslau et al, 1995; Earls, 1987; Kessler et al, 1993, 1994; Nolen-Hoeksema, 1987; Schneier et al, 1992; reviewed in Seeman, 1997; Young, 1998; Young and Korszun, 2002). Studies in humans suggest that differences in ER isoform expression in the brain may have some functional importance for affective disorders and efficacy in their treatment (Osterlund and Hurd, 2001; Osterlund et al, 2000, 2005). E2 administration to women with anxiety or depressive disorders can enhance mood (reviewed in Walf and Frye, 2006). However, a serious criticism of E2-based therapies are their potential to enhance proliferation in E2-sensitive reproductive tissues, which are mediated primarily via actions at ERα (Gustafsson, 2003). Indeed, these findings underscore the importance of further investigating the tissue-specific functional effects of ERα and ERβ.
References
Andrade TG, Nakamuta JS, Avanzi V, Graeff FG (2005). Anxiolytic effect of estradiol in the median raphe nucleus mediated by 5-HT1A receptors. Behav Brain Res 163: 18–25.
Becker JB (1990). Estrogen rapidly potentiates amphetamine-induced striatal dopamine release and rotational behavior during microdialysis. Neurosci Lett 118: 169–171.
Becker JB, Snyder PJ, Miller MM, Westgate SA, Jenuwine MJ (1987). The influence of estrous cycle and intrastriatal estradiol on sensorimotor performance in the female rat. Pharm Biochem Behav 27: 53–59.
Breslau N, Schultz L, Peterson E (1995). Sex differences in depression: a role for preexisting anxiety. Psychiatry Res 58: 1–12.
Bryant DN, Bosch MA, Ronnekleiv OK, Dorsa DM (2005). 17-β−estradiol rapidly enhances extracellular signal-regulated kinase 2 phosphorylation in the rat brain. Neuroscience 133: 343–352.
Choleris E, Gustafsson JA, Korach KS, Muglia LJ, Pfaff DW, Ogawa S (2003). An estrogen-dependent four-gene micronet regulating social recognition: a study with oxytocin and estrogen receptor-alpha and -beta knockout mice. PNAS 100: 6192–6197.
Earls F (1987). Sex differences in psychiatric disorders: origins and developmental influences. Psychiatr Dev 5: 1–23.
Edinger KL, Frye CA (2007). Androgens' effects to enhance learning may be mediated in part through actions at estrogen receptor-β in the hippocampus. Neurobiol Learn Mem 87: 201–208.
Etgen AM (1987). Inhibition of estrous behavior in rats by intrahypothalamic application of agents that disrupt nuclear binding of estrogen-receptor complexes. Horm Behav 21: 528–535.
Etgen AM, Shamamian P (1986). Regulation of estrogen-stimulated lordosis behavior and hypothalamic progestin receptor induction by antiestrogens in female rats. Horm Behav 20: 166–180.
Frye CA, Bayon LE (1999). Mating stimuli influence endogenous variations in the neurosteroids 3α,5α-THP and 3α-Diol. J Neuroendocrinol 11: 839–847.
Frye CA, Duncan JE (1996). Estradiol benzoate potentiates neuroactive steroids' effects on pain sensitivity. Pharmacol Biochem Behav 53: 27–32.
Frye CA, Petralia SM, Rhodes ME (2000). Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3α,5α-THP. Pharmacol Biochem Behav 67: 587–596.
Frye CA, Walf AA (2002). Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav 41: 306–315.
Frye CA, Walf AA (2004). Estrogen and/or progesterone systemically or to the amygdala can have anxiety, fear, and pain reducing effects in ovx rats. Behav Neurosci 118: 306–313.
Frye CA, Wawrzycki J (2003). Effect of prenatal stress and gonadal hormone condition on depressive behaviors of female and male rats. Horm Behav 44: 319–326.
Garcia-Ovejero D, Veiga S, Garcia-Segura LM, Doncarlos LL (2002). Glial expression of estrogen and androgen receptors after rat brain injury. J Comp Neurol 450: 256–271.
Greco B, Blasberg ME, Kosinski EC, Blaustein JD (2003a). Response of ERα-IR and ERβ-IR cells in the forebrain of female rats to mating stimuli. Horm Behav 43: 444–453.
Greco B, Lubbers LS, Blaustein JD (2003b). Estrogen receptor β messenger ribonucleic acid expression in the forebrain of proestrous, pregnant, and lactating female rats. Endocrinology 144: 1869–1875.
Gustafsson JA (2003). What pharmacologists can learn from recent advances in estrogen signaling. Trends Pharmacol Sci 24: 479–485.
Hardy DF, Debold JF (1971). Effects of mounts without intromission upon the behavior of female rats during the onset of estrogen-induced heat. Physiol Behav 7: 643–645.
Hatton WJ, von Bartheld CS (1999). Analysis of cell death in the trochlear nucleus of the chick embryo: calibration of the optical disector counting method reveals systematic bias. J Comp Neurol 409: 169–186.
Howard CV, Reed MG (1998). Unbiased Stereology. Three-Dimensional Measurement in Microscopy. Bios Scientific Publishers: Oxford.
Imwalle DB, Gustafsson JA, Rissman EF (2005). Lack of functional estrogen receptor β influences anxiety behavior and serotonin content in female mice. Physiol Behav 84: 157–163.
Joyce JN, Van Hartesveldt C (1984). Estradiol application to one striatum produces postural deviation to systemic apomorphine. Pharmacol Biochem Behav 20: 575–581.
Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB (1993). Sex and depression in the National Comorbidity Survey I: lifetime prevalence, chronicity and recurrence. J Affect Disord 29: 85–96.
Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S et al (1994). Lifetime and 12-month prevalence of DSM-I1I-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51: 8–19.
Krezel W, Dupont S, Krust A, Chambon P, Chapman PF (2001). Increased anxiety and synaptic plasticity in estrogen receptor β-deficient mice. PNAS 98: 12278–12282.
Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA (1996). Cloning of a novel receptor expressed in rat prostate and ovary. PNAS 93: 5925–5930.
Kuiper GG, Shughrue PJ, Merchenthaler I, Gustafsson JA (1998). The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems. Front Neuroendocrinol 19: 253–286.
Liang YQ, Akishita M, Kim S, Ako J, Hashimoto M, Iijima K et al (2002). Estrogen receptor beta is involved in the anorectic action of estrogen. Int J Obes Relat Metab Disord 26: 1103–1109.
Lund TD, Rovis T, Chung WC, Handa RJ (2005). Novel actions of estrogen receptor β on anxiety-related behaviors. Endocrinolgy 146: 797–807.
Mhyre AJ, Dorsa DM (2006). Estrogen activates rapid signaling in the brain: role of estrogen receptor alpha and estrogen receptor beta in neurons and glia. Neuroscience 138: 851–858.
Morgan MA, Pfaff DW (2001). Effects of estrogen on activity and fear-related behaviors in mice. Horm Behav 40: 472–482.
Morgan MA, Pfaff DW (2002). Estrogen's effects on activity, anxiety, and fear in two mouse strains. Behav Brain Res 132: 85–93.
Morgan MA, Schulkin J, Pfaff DW (2004). Estrogens and non-reproductive behaviors related to activity and fear. Neurosci Biobehav Rev 28: 55–63.
Nolen-Hoeksema S (1987). Sex differences in unipolar depression: evidence and theory. Psychol Bull 101: 259–282.
Nomura M, McKenna E, Korach KS, Pfaff DW, Ogawa S (2002). Estrogen receptor-beta regulates transcript levels for oxytocin and arginine vasopressin in the hypothalamic paraventricular nucleus of male mice. Brain Res Mol Brain Res 109: 84–94.
Ogawa S, Chan J, Chester AE, Gustafsson JA, Korach KS, Pfaff DW (1999). Survival of reproductive behaviors in estrogen receptor β gene-deficient (βERKO) male and female mice. PNAS 96: 12887–12892.
Ogawa S, Chan J, Gustafsson JA, Korach KS, Pfaff DW (2003). Estrogen increases locomotor activity in mice through estrogen receptor α: specificity for the type of activity. Endocrinology 144: 230–239.
Ogawa S, Eng V, Taylor J, Lubahn DB, Korach KS, Pfaff DW (1998). Roles of estrogen receptor-alpha gene expression in reproduction-related behaviors in female mice. Endocrinology 139: 5070–5081.
Osterlund MK, Gustafsson JA, Keller E, Hurd YL (2000). Estrogen receptor β (ERβ) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERα mRNA. J Clin Endocrinol Metab 85: 3840–3846.
Osterlund MK, Hurd YL (2001). Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol 64: 251–267.
Osterlund MK, Witt MR, Gustafsson JA (2005). Estrogen action in mood and neurodegenerative disorders: estrogenic compounds with selective properties-the next generation of therapeutics. Endocrine 28: 235–242.
Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press: New York.
Pfaff D (2005). Hormone-driven mechanisms in the central nervous system facilitate the analysis of mammalian behaviours. J Endocrinol 184: 447–453.
Pfaff DW (1980). Estrogens and Brain Function: Neural Analysis of a Hormone-Controlled Mammalian Reproductive Behavior. Springer-Verlag: New York.
Pfaff DW (1999). Drive: Neural and Molecular Mechanisms for Sexual Motivation. MIT Press: Cambridge, MA.
Phillips MI (1978). Angiotensin in the brain. Neuroendocrinology 25: 354–377.
Pleim ET, Brown TJ, MacLusky NJ, Etgen AM, Barfield RJ (1989). Dilute estradiol implants and progestin receptor induction in the ventromedial nucleus of the hypothalamus: correlation with receptive behavior in female rats. Endocrinology 124: 1807–1812.
Rachman IM, Unnerstall JR, Pfaff DW, Cohen RS (1998). Estrogen alters behavior and forebrain c-fos expression in ovx rats subjected to the forced swim test. PNAS 95: 13941–13946.
Rocha BA, Fleischer R, Schaeffer JM, Rohrer SP, Hickey GJ (2005). 17β-Estradiol-induced antidepressant-like effect in the Forced Swim Test is absent in estrogen receptor-β knockout (BERKO) mice. Psychopharmacology 179: 637–643.
Schneier FR, Johnson J, Hornig CD, Liebowitz MR, Weissman MM (1992). Social phobia. Comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 49: 282–288.
Seeman MV (1997). Psychopathology in women and men: focus on female hormones. Am J Psychiatry 154: 1641–1647.
Shughrue PJ, Lane MV, Merchenthaler I (1997). Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J Comp Neurol 388: 507–525.
Shughrue PJ, Merchenthaler I (2001). Distribution of estrogen receptor beta immunoreactivity in the rat central nervous system. J Comp Neurol 436: 64–81.
Shughrue PJ, Scrimo PJ, Merchenthaler I (1998). Evidence for the colocalization of estrogen receptor-β mRNA and estrogen receptor-α immunoreactivity in neurons of the rat forebrain. Endocrinol 139: 5267–5270.
Slater J, Blizard DA (1976). A re-evaluation of the relation between estrogen and emotionality in female rats. J Comp Physiol Psychol 90: 755–764.
Vasudevan N, Kow LM, Pfaff D (2005). Integration of steroid hormone initiated membrane action to genomic function in the brain. Steroids 70: 388–396.
Vasudevan N, Kow LM, Pfaff DW (2001). Early membrane estrogenic effects required for full expression of slower genomic actions in a nerve cell line. PNAS 98: 12267–12271.
Wade CB, Dorsa DM (2003). Estrogen activation of cyclic adenosine 5′-monophosphate response element-mediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway. Endocrinology 144: 832–838.
Walf AA, Frye CA (2003). Anti-nociception following exposure to trimethylthiazoline, peripheral or intra-amygdala estrogen and/or progesterone. Behav Brain Res 144: 77–85.
Walf AA, Frye CA (2005a). Estradiol's effects to reduce anxiety and depressive behavior may be mediated by estradiol dose and restraint stress. Neuropsychopharmacology 30: 1288–1301.
Walf AA, Frye CA (2005b). ERβ-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovx rats. Neuropsychopharmacology 30: 1598–1609.
Walf AA, Frye CA (2006a). A review and update of: mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 31: 1097–1111.
Walf AA, Frye CA (2007). Administration of estrogen receptor β-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol Biochem Behav 86: 407–414.
Walf AA, Rhodes ME, Frye CA (2004). Anti-depressant effects of ERβ selective estrogen receptor modulators in the forced swim test. Pharm Biochem Behav 78: 523–529.
Walf AA, Rhodes ME, Meade JR, Harney JP, Frye CA (2007). Estradiol–induced conditioned place preference requires actions at estrogen receptors in the nucleus accumbens. Neuropsychopharmacology 32: 522–530.
Young EA (1998). Sex differences and the HPA axis: implications for psychiatric disease. J Gend Specif Med 1: 21–27.
Young EA, Korszun A (2002). The hypothalamic-pituitary-gonadal axis in mood disorders. Endocrinol Metab Clin North Am 31: 63–78.
Acknowledgements
This research was supported by grants from the National Science Foundation (IBN03-16083) and US Army Department of Defense (BC051001) and Ministerio de Educacion y Ciencia, Spain (SAF 2005-00272).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Walf, A., Ciriza, I., Garcia-Segura, L. et al. Antisense Oligodeoxynucleotides for Estrogen Receptor-β and α Attenuate Estradiol's Modulation of Affective and Sexual Behavior, Respectively. Neuropsychopharmacol 33, 431–440 (2008). https://doi.org/10.1038/sj.npp.1301416
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.npp.1301416
Keywords
This article is cited by
-
Periodic Estrogen Receptor-Beta Activation: A Novel Approach to Prevent Ischemic Brain Damage
Neurochemical Research (2015)
-
Oral Contraceptives and Nicotine Synergistically Exacerbate Cerebral Ischemic Injury in the Female Brain
Translational Stroke Research (2013)
-
Viral Vector–mediated Delivery of Estrogen Receptor-α to the Hippocampus Improves Spatial Learning in Estrogen Receptor-α Knockout Mice
Molecular Therapy (2008)